-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B1KKOIz2E81d52RWW7hOLHe94l9BDI2DGG9j/VOs6FZOXk0wFF9aLo0leuB90Css yhdKgs73BGbr8PL0wJ/8EQ== 0000950103-06-002648.txt : 20061122 0000950103-06-002648.hdr.sgml : 20061122 20061122095451 ACCESSION NUMBER: 0000950103-06-002648 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20061121 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20061122 DATE AS OF CHANGE: 20061122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shire plc CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 061234672 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: - BUSINESS PHONE: 1264333455 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: - FORMER COMPANY: FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC DATE OF NAME CHANGE: 19980302 8-K 1 dp04069_8k.htm
 
 
UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION 
 
Washington, D.C. 20549 
 
FORM 8-K
 
CURRENT REPORT
 
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 

Date of Report (Date of earliest event reported):  November 21, 2006

Shire plc

(Exact name of registrant as specified in its charter)
 
England and Wales

(State or other jurisdiction of incorporation)

0-29630   98-0484822
(Commission File Number)   (IRS Employer Identification No.)

Hampshire International Business Park, Chineham, Basingstoke,
Hampshire RG24 8EP England

(Address of principal executive offices) (Zip code)
   
Registrant’s telephone number, including area code 44 1256 894 000

 

(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Item 8.01. Other Events

     Shire plc has issued the press releases attached as Exhibit 99.01 and Exhibit 99.02 which are incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits

  (c) The following exhibits are filed herewith:
     
99.01   Press Release dated November 21, 2006
     
99.02   Press Release dated November 21, 2006

 





SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SHIRE PLC
     
By:  /s/ A C Russell
 
  Name: Angus Russell 
  Title: Chief Financial Officer

Dated: November 21, 2006






EXHIBIT INDEX


Number Description
   
99.01 Press Release dated November 21, 2006  
   
99.02 Press Release dated November 21, 2006





EX-99.1 2 dp04069_ex9901.htm
     
    EXHIBIT 99.01
  Hampshire International Business Park
Chineham Basingstoke
Hampshire RG24 8EP
United Kingdom
Tel +44 (0)1256 894000
Fax +44 (0)1256 894708
www.shire.com
     
  Press Release  
     

21 November 2006

Shire plc (the "Company")

Notification of the Exercise of an Option and Sale of Shares by a Person Discharging Managerial Responsibilities.

The Company announces that it was notified, on 20 November 2006, by Mr John Lee, Executive Vice President Global Supply Chain & Quality, that, on that day, he exercised the following options over ordinary 5p shares in the capital of the Company:

No of shares Exercise price
81,227 £3.38
50,000 £5.25

The Company further announces that on 20 November 2006 it was notified by Mr Lee of the sale in London, on the same day, of the same 131,227 ordinary 5p shares in the capital of the Company at a price of £10.55.

Following these transactions, Mr Lee’s holding of ordinary 5p shares in the capital of the Company remains unchanged at 1,928.

T May
Company Secretary

For further information please contact:
     
Investor Relations Cléa Rosenfeld (Rest of the World) +44 1256 894 160
  Brian Piper (North America) +1 484 595 8252

Notes to editors

SHIRE PLC
Shire’s strategic goal is to become the leading specialty pharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire

Registered in England 2883758 Registered Office as above






believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

Shire’s focused strategy is to develop and market products for specialty physicians. Shire’s in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.

For further information on Shire, please visit the Company’s website: www.shire.com.

 

Registered in England 2883758 Registered Office as above






GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(" M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@," M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$! M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,` M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I M*C0U-CH.$A8:' MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7 MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1 M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`#@`MP,!$0`"$0$#$0'_V@`, M`P$``A$#$0`_`/WXH`*`"@`H`\V^*?Q<^'_P7\+3^+OB'K]OH6E1N8+2+:UQ MJ>KWI0NFG:-IL.9M0O7`^Y&NU!EY&2-6<=V79;C,SQ"PV!HNK4W;^&$(_P`T MY/2,?-[[)-Z&=6K3H1YIRY4MN]^R1^4GQ!_X*H>(Y+NXM_A=\-='TW3$+I!J M_CN]NK[4)D!(6X_L;1;BV@L=RX/EO?W.._H/T3!>'M",8O'XZU*DHKO)Z_% M-4L(;F,=?LCC7XI[F$Y'[V/>O'WJ[_\`4?('>G3JXA3CORU8-Q]5[-J+\G9^ M1E_:&)6O+&W3W6OU,V#_`(*`_';QGXEM+'Q)\2M.^$'A.\FV7>J^!_AMI_BF MZTE&("R&SUO4);NZ@7/SM#<"10,K'(?EK1\&Y1@Z$I8?`2S'$17NPKXF5%3^ M=.*C%]KQL^Z$L?7E)*5148=XP3M\F[GWS9Z1^U%HW@NW^+/PF_:8\/\`[0N@ M)ISZ\/"?B7P-HFDV/BO3+-6FO+'1==T"X^TZ;J[)%-$D,OE%)E,4VUP5'QTJ MG#]3%/+\=5IJ=RCB8P]K1Q*KQ2 MORN*5UU2:V9Q'Q;_`."CDGPU\4:;H6G_``G&MV>J>"_!7C&WO+OQ4^DW4<7C M'P]9Z\EC/9+H5P$EM1=B%F\P[RA;"YP.O+>!UCC4 ME3];XDGM;S/;OV3/VN+C]IJ^\;6<_@2+P: M/!]IH=RLD6OMK7V_^V9M2B*%6TJS^S^5]@!SF3=YO0;>?*XCX;CD$,)*.+>) M^LNHK.G[/EY%%_SRO?F\K6-\+BOK#FO9^SY+=;[W\EV/M2OE3L"@#@/BKXW; MX:?#?QOX_CTU=7?P?X;U37UTIKDV2WYTZV>X%J;L0R_9A)MQYGE28SG::[,N MPBQV.PF"Y_9+$U84^:U^7G=K\MU>W:ZN9U9^RISFE?D3=MMOR/RJ;_@J]?JC M-_PH^U^52V/^$\D'09Q_R+%?H?\`Q#J'_0V?_A.O_EIYG]J/_GQ_Y-_P#]=/ M">MGQ+X5\,^)&MA9'Q!X?T;7#9B7SA:'5].MK\VPFV)YPB-QLW[%W;,[1G`_ M-L12^K8BOA^;F]A4G3O:U^23C>VMKVO:[/5@^:$96MS).WJKG05B4%`!0`4` M%`!0`4`%`!0`4`<_XI\5^&O`^@ZAXG\7:YIOASP_I4)GO]6U6ZCM+.W0`X!> M0@R3.?E2*,-)(Q"HK,P!VP^&KXJM##X6C*M6J.T803;^Y;+NW9):MI$RG&G% MRE)0BMV]#\$?C"/B)^V/\3/%?Q+L[ZU\*?`7P7-<:1H/C_QQ<3^'_!&@^&[* M0)+>VRW"^?K'B+59P;I[*PAGNF:>VMGV")`/V'+/J7"^`PV`E!U\XQ24ZF'H M)5*\ZLE=1=M(4Z:]U3FXPTE-7NSPZWM,74E43]G0IZ*4M(Q7?S;WLM=D>B?L MW?LS>$?BR=9G^%=S)#X<\,WZ:1JOQT\>>'[?5-=UK6Q`EU-9_"WX;7+A^/\50Y8 M/*\-&A':%)SIM+R=Y*_FXZ]3>660Z5IJ7=V?^7YGY._'#X)>,O@#X[N_`GC) M+::=;:/4M&UG3_,_LS7]&N))8K?4K'S0'B_>PS0RP2?/#+"Z$LNUW_176HSP\W3EIU36S3ZH^P/^"(M-L84M;'3_``EX"LK.VC&V.WM;7PW: MP6\,8[(D2(H'HM=W!DI3R&A.3O.=;$2DWNVZK;?S9GCTEB9):)1BE\D?37_! M*7_D-_&G_L%>"?\`TK\15X/B'_!RK_'7_P#2:1T97\5;TC^I^S6/\]*_+]OD M>P%`'`_%/P0?B3\./&W@!=2&CMXO\-ZIX?75#:_;1IYU&V>W%T;,3P_:=F[= MY?FQ[L8W#K79EV+^H8["8SV?M/JM6%3DORWY7>U[.U^]GZ&=6'/3G33Y>9-7 M[7\C\KF_X)/7;(R_\+SC&Y2N?^%?-QD8SC_A+*_0O^(B1_Z%+_\`"C_[B>9_ M97_3[_R3_P"V/UP\)Z&?#/A;PSX:-S]L/A[P_HVAF\$7D?:CI.G6U@;GR-[^ M3YOV??Y>]]N_&XXR?S?$5?;XBO7Y>3V]2=3EO?EYY.5KZ7M>U[*YZL(\L8Q_ ME27W*QOUCMY%!CTH#;R"@`H`7!]/Z?\`ZJ-@$Z>V/PQF@`H`*`"@#YX_:!_: M4\`?L]:'!<>())M:\7:P&B\)^`M%99O$/B&[9Q#"5A0.;#3?M#)&UW*A!8E( M4FFQ$?:R;(L9G-5QH)4,-2UJXB>E.DMWKIS2MJHI^';>9=0\$_L_Z5/<66B:/;R$20 MS^+%CE$DEXT6P20.[74@)6XEA0&T'OXK.\OR&C/+N&HJ5=KEKYA))U)OJJ.E ME&][-+E6\5)^^VQ^7'[5/Q-^(WBKXD>(?`/ MBR.U\,^&OAIK^I^&_"WPZ\/V_P#9?A/P]9:9N] M3S,54J.I*G+W(TVU&"TC%+;3S74]N_8Q_;0T7]GO1M5\`>.O#^IZAX.U779? M$%IK?A]8;C5-%O[RTL[.]BNM+GEB&H:?(EC;2*T,RRQ,)!Y7Y7%'"U7. M:M/&8.M&GB:=-4W3J74)Q3E*+4DGRR]YK56:MJK:[X/&1PT73G%\C=TUNGUT M['Z]^`?VJ/V??B2(8_"WQ2\+M?2HK#1]9O?^$A-?FN,X>SG`7]OE]6,(_;A'VD/7FI\R2];'K4\3AY_!5C?L_=?W.QG?'+]E MOX4?M&W7AK5O'C>(//\`#=G?6FE77AG6HM,6:SU26VN)5N7^R7`N462V5HR" MH7S9.N_B\IX@S'(HUZ6#5-1K2BY1JP%;\ZCI:ZEXGCN[`W#6\]J1=6JZ9& M9HO*N)/EWKS@YXKMQO&&;X_"5\'76'5&O'EERTN65KIZ/F=G==B*>!H49QG# MFYH.ZN]/NMYGY5_\%$O^3I_%_P#V+G@K_P!,$%?H7!/_`"3V&_Z^U_\`TXSR M\P_WF7I'\C#_`&6_VE+7]FSPY\7]5LM.CUCQIXIM/">E^#],NA*NF)/:3:]+ MJ&K:O+$RM]ALH[BW/D1LLEQ)/'&K(I>2/;B#(I9W7RRE*;HX7#RK2K2C;FLU M34803TYIM/5JT4F[-V3G"XA86-5I7G+E45TZW;]+[=3QGQU^T3\9_B3JDVJ> M+/BEXKO)9IG>*PTW7+O0M%L][$B#3]&T:>WM;:)>@`1G.,LS-DGU,'DF5X"F MJ>&R^C!16LI4U.;\Y3FI2;^=NR1C/$5IN\JLO1.R7HE9&_\`#G]J'X]?"W4[ M6_\`#?Q*\2W=K;RI)/H'B;4[SQ)X>OXP?GM[K3]5GE,2NI9?-M9+>9=V4D4@ M5CC>'\GQ].4*V`I4Y-:5*48TJD'W4H)?=)-/JF53Q->BTX5'9=&[K[G^A^WK M_M"M\5/V.?'/QE\%7%SX6\2V/@;Q.MW%93J]WX6\8:)9L+N*UN'C(=$E,-U; M2.F7@NH&90S%1^4+)?[-XGPF5XJ*KX>6(I1^);_`+7'[3@C-]:Q/_`#^E^'^1]T_MI_'7XQ^`;#]G>3P7\1_$WAE_ M$WPCLM:\0MIEQ;1'5]6DAT=GU"\\RU?=%]1N[0R:QXMN=>T6TTJRL-EK'Y5S)'-=;YF MW+#;K<2LK"/![\^X5P=>E@3:M;^M%<^S2LQR0$4[![F6\-Y1E=.,:.$A6JQ M7O5JT8U*DGU?O)Q@G_+!)+SW.>KBJ]5OWW"/2,79+[OU/TS_`&3/CSH7PE_8 MUG^(WQ.\0:OJ<=AXX\5:9I<%YJ%QJNO:W?-):G3M`T@ZC3LE=L]'"5XT,' M[2I)Z2:2O=WZ)7/@3XP_MV_'OXH7]XNE^)KKX9^%"\@L_#O@RY;3[M+4\+_: MWB1%6_O[ED`,GE26L&XMLA4=?LU>\\#@'%TOJ6'<5]GV-+3YTJ+7VDEY\TO\S[6^`/\` MP4*^*OPZU:PTGXIZC>_$OP)+,D-[<:@(I/&>B0N0K7VFZLJHVL+$,.UG?F1I M%5A%/&Y^;Y7.."\NQE.=3+J<\L;N-9 M89D/!0[6PR,%=&5D=592!^05Z%7"UJF'KTW1K49.$X/1QDG9K_@K1K5:'NQE M%Q4HOW6KIKLS:K(9\?\`[5G[5>D?L_Z-::!H%HGBCXM^*HQ!X1\)P!KDVANG M-K;:UK-M;GSC9F\*Q6]I&!+>S`Q1[4622/Z;AWAVIG%65:K+ZMEN&UK57[M[ M:N$&].;EUE)Z0CJ]6D^3%8I8=*,5>K+X8]O-I?@NIQ/[,7[+6L:)K,GQZ_:! MNG\8_';Q*RZC`NJLEW;>`H)D_<6EE",V\>M1P.(]T"B&Q0"WM`-LDLW5GW$% M*I263Y+'ZIE&']U\GNO$-;RD]^1O776;]Z=]$HPV%<7[>O[U=ZJ_V+]O/\MD M?>U?'G MK@VM;M--N_#BL%&O[\'[.HON?:_9^9^+GQ(_9K^.?PFFG7QI\-O$5K86[,O] MO:19OX@\.RJ.?,35]'6>*)"O.+@0.`?F0'('ZE@<]RG,%'ZICJ;F_P#EW-^S MJ+RY)V;_`.W;KS/'J8:M0^*FTEU6J^]'A1\IR4(1BAPR,%+(P[,IY5@?4`UZ M^JVT[&!ZM\/_`(V_%SX5W45SX!^(?BGP\D+HW]G1:G/>:),$(81W.A:B9["> M(X&5:#Z$5YV,RG+H6_PW^)-G8:!\26MI9-%U/3@;?0O&2VD1ENH(+65V;2M>2!) M)S:AY(9TCE:!D*>37Y=Q+PD\I@\=@)2J8&+2G"6M2A=V3;7Q4VVES63BVN:] M^8]C"8U56J=1*-3HUHI?+H_+J?G;_P`%$O\`DZ?Q?_V+G@K_`-,$%?:\$_\` M)/8;_K[7_P#3C//S#_>9>D?R(/V$/@5X<^-WQ?NU\9V2ZEX0\#:'_P`)'J>C MREUM=:U&>\BL=&TV]V$%K'S6N;J6+($HL1$V4D<&N+\WKY1ED?JLO98G%U/9 M0FMZ<5%RG*/:5K13Z&-KQK1?,I^UGS7\[O7S3T?4]QTJ7+R^SCR[6LC^9O\`:%^'%G\)/C5\ M1?A]IAF.D^'M?D71?M#F2=-%U*VM]6TF&:4X,LL-C?P0F0\N8MQY8U^[Y+CI M9CE6"QD[1J5J?OVT7/%N$VET3E%NW2]CYS$4U1K5*<=%%Z>CU7X,^Q_V2]6N M)/V1?VR]"9W-M8>'_P"UH(R?W<&=4M+DJ,\,ZZ/;9XYVBOF.(Z2CQ)PO M52M*53D?I"K"2_\`2V=>$=L+BX]$K_>G_D?F?)_JI/\`KFW_`*":^\6Z/./T M<_X*`?\`(-_9:_[(?8?^B-"KXC@W^)Q!_P!ATOSJ'H8[;"_]>U^A\*>`_!.N M_$;QGX9\">&($GUWQ3J]KI&G+*2EO#)<,3-=W3J"8K2VMEFN)G`^6*!R,G@_ M6XS%4<#A:^+KOEHX:#G*V^FT5YR=HI=6T<5.$JDXTXK63LNF_P#5S][OAS_P M3N_9V\'Z):VOBSP]<=,T?2KVVM["TWY"( M_GR@8WRL3FOQ_&\:YWB*LI8:LL!0O[E.G&#:73FG.,I2?=JR[)'N4\OP].*4 MH^TEU;;7W)-61^5_[;$_A3PS\47^"WPVTI/#?PZ^%^^2VT"TO+^ZL?\`A,?% M-M9ZMXFU4&_NIY!,86TRR"F0K&+&0(%$K`_H/"D<16R]9ICJGML;C]'4:C&7 ML:3E"E#W5%6OSSVUYE>]D>9C.2%7V-))M9\ M1_$CXMZGX0:U\*7EEI?A3PSXJU;2+6RN]8EA^VWFMWNF:E]NG0_9/4_$'P(UG2)M`U;7OA-J.ASP-:RZ1> MZOX1N-.:W92AA^QR7!B5-IP`%&.V,5^84Z&;T:BJTJ.,IU8NZG&%923WO=*Y M[#E0:Y7*#CVO&WW'\[/[4_PU\)_"SXS^(_#_`(!U73=5\$ZA%:>(?#+Z7JEM MJ]OIUAJRR&;16N[6XFR;'4(+R",2.9/(6W9\EMS?M?#V.Q&/RNA5QE.5+%4W M*G54H.#E*&T^5I?'%INRMS-G>R>ZT[/\#]*O^"77Q.O M-7\'^.?A1J-R\J^#;ZS\1^'%D=F:WT?Q$]Q%J=C%N/R6T&KVOVA5'`;5I*^% MX_R^-+$X3,:<>7ZU&5*K;2\Z=G&3\W!V?E!'HY94?).D_L-->CW7WZ_,^\/C M]\9M$^`OPO\`$'Q"UA$NI[&-+'P]H[2>6^N^)+\/'I6EHPY6)I%>>=UYCMK6 MXD`)0`_(9-E=7-\PHX*E[L9>]4G;^'2CK.?KTBNLG%=3NKUHX>E*;WCHEM=O M9?Y^1^>7["'PIUKXN>-?$O[6WQM+=R M5M[+2XV72M,B0;(##\KQOHVC@P-)U)RQ57>[Y?7JTNEME\^Q^NE?FQZIQ/Q(\<6/PS\!^*_'V MIV%_J6G>$=%N]E?$WP%X4\? MZ'#+M%M=9LK6]\DW=M%=H=UK=BWDDB^T12!XY`CNH9&`)Q7QF.PE3+\ M9B,%5:=3#3<&XWLVNJND[-:JZ6C.^G-5*<)QT4E=+U.1\=?L\_!'XDI(OC3X M8>$-8GEW;M1&DP:=K`9L_.FLZ6+:]5P3D$3]:Z<'G6:X!KZICZU&,=H\[E#_ M`,`ES0_`B>'HS^.E'[K/[U9GX[?MH_L4Z+\"-$M?B5\.-4U&X\$W6KVVCZMX M=UJ<7E_X?N]064V%S8:GL1[[2I9H7@:.Y5IH7DA/FRJ[>7^F<+<4U*J4F^2]FGTOM9]OR/@ M+PGX@U'PCXI\->*=(GDM=4\.:]I.M:?/$S))'=:;?074>"O.&,>QA_$KL#D& MOLL31AB,/7P]1)TZU.<))[6G%I_F<$).$HRCHXM-?>?7'_!0>X%U^T[XENE4 MHMSX4\!W"HP(*"?PW:RA2#R"-V*^;X,CR9!0C_)6Q"^ZJSKQ_P#O,K:>['\4 M?2W_``2E1/[?^-$FT;UTCP6BMW"/>^(&91[$HI_"O"\0W^YRM+1<]?\`])IG M1E?Q5O)1_-G[.5^7'L'\VO[>O_)UWQ3^OA#_`-0?PY7[GP?_`,D[E_\`W&_] M/U3YW'?[U4_[=_\`24>K?LC_`/)L?[;'_8D:7_Z9?%E>=Q)_R/N%?^PB7_I= M$UPG^[8S_"ORD?G+)_JI/^N;?^@FOMUNCSS]'/\`@H!_R#?V6O\`LA]A_P"B M-"KXC@W^)Q!_V'2_.H>ACML+_P!>U^AR7_!.6QMKO]I_09IXU=],\)>,;ZTW M`$171T^*Q\T9Z,+>^N%!']^NCC>(CV( MQ7[]PXU_8.5-A(HVDDC.0:K,<_RS)JE.CC MJ\Z,ZL>>*C3G-.-W&]X*RU3T%2PM6LG*G%6B[/5*SWZ^IZM_P[J_:D_Z)YX< M_P#"S\*?_)E>?_KMP_\`]!M7_P`$5O\`Y$U_L_$_\^U_X%'_`#)$_P"">'[5 M40VQ^`=!C7.=J>-O"R#)ZG"WPYI?ZZ\/?]!E3_P15_\`D0_L_%+_`)=I?]O1 M_P`S[@_80_9@^-_P,^)_BKQ#\1O#NGZ)H&K^!I]&@FL_$>CZN\VJC7-'O;>) M[;3KF22-1;6]ZWF,H4'C.6&?D^+L_P`IS7+\/0P-:52M2KJ;4J4Z=H>SG%N\ MDENUIN=N!PU:A5E*<5&+C;1IZW3V1Y?_`,%5/%6J/XK^%7@A7>/1K3P]K'BP MP@E8[G5;[4/['CED'1VM[2QF5"?NB_E_O\^AX>8>G'#YABK?O95(4;]8P4>= MI=N:4E?ORKL9YI)J5*&T4G+YWM_7J?I9^RW8Z-IO[.GP8M=`>&33C\/O#UUY MD&W8^H7]DE]K#-M/$QU>XOO,!.1)O#<@U\)Q!.K+.\T=5-3^L5%9](QERP^7 M(HV\K'HX51CAZ*CHN5?>]7^-SWNO'-SG/&'AFP\9^$_$WA#5`?[-\3Z#JV@7 MI"@E+;5[&>QED0'C>BSEU]U%;X6O/"8FAB:>D\/4A4CZPDI+[[$SBI0E!Z*2 M:^]6_4_E*^(7@+Q%\+_&GB+P#XKLY++7/#.HS:?*DN\7]J,ETE%WC)=&CY>I3E1G*G M)6<';_)^CW/N+]D;]NF3X%:%'\./B%HVI^(?`$%W/ZDEN$C6:&6%YY=OFHZI'\GQ)PBLVJO&X&K&AC&DJD)W5.KRJ MT9S3;[<)C?J\?93BY4ULUO'J].J/T3'_!13]EG[%]K_P"$ MNU]9/+W_`-GGP7XC%\&_YY;18^3YG_;;;_M5\3_J3Q!SA_:&%M\3].5W_(_.3]L?]M>R^/\`H]C\/?`6AZEHW@2RU6#6=2U/7D@@ MUGQ#?622II\4=A;33+INF0-/),5DF>6:01%EB$6V3[CACA66359XS%U8U,7* M#A&%.[A3C*W,^9I,5=*G3BXTT[MO1M]-.B_,^6?V??A7 MJWQE^+O@OP+I=M-+;76KVFH>(;F-"8M+\,:;\?\%#U6/\`:E\6(BA$3PWX(15`P%5?#]N%`'88`KR."O\`DG\-_P!? M:_\`Z<9OF'^\R](_D?27_!*7_D-_&G_L%>"?_2OQ%7A>(?\`!RK_`!U__2:1 MT97\5;TC^I^S5?EY[!_-K^WK_P`G7?%/_>\(?^H/XC4PCC'&83FY8R?*JD)6FLDVKW,\%B5AI2C+^'*V MW1][=M=3]B;C]LS]EZVTIM8/QG\(26JH76"VFO9]4=RY+>=SU_KF&2O[:*7;K]VY^7?QQ_X*-_$ M_7?&TK?`_59/!G@/3[865F-6T#1-0U;7[D2R/-K=Y%J5K9[N4K:MV6BN_,K9A4< M_P!P_9TX[72N_/7;T/T#_8:\9_'+XF?#K5_B-\8_$1U6QU_4TM?`EI_8>D:+ MC2=+$T.I:U_Q++&!KB&\U&1H(3(6&W3&=!MF!/QG%N%RG+\;3P.5T/92H0O7 M?M)S]^=G&'O2=G&.KMUG9['?@IUITW4JRTD_=5DM%N]$MW^1Z)^TK^RYX)_: M3T'3;/7;R\\.^)_#IN6\-^+-,ABN+FPCO/+-YI]]8SLL>IZ5.T,+M`9(G22) M7BEC)<2<61<08K(JU25&$:V'K6]I1DW%2Y;VE&2UA-7:O9IIV:>EM,1A88B* M3?+*.TETOTMV9\R_"C]F']L;X$6[^'_AQ\=_AKJ7@P7,L]OX>\9>'=?N["U: M9WEFDLK6)99]*::5M\D5IJ"Q,\CR%"Q);WLQS_AC-VJV-RC%4\59)U*%2G&3 MMLI-V4K+9RA>UE>QS4L+B\/[M*O#D_EDG;7MV^3/JS1O#/[3=ZB+XM^*OPPT M0*%#CP-\,M4NKIR/O,E[XK\77$$+MSR=/D7H=O8_/5:^00O]6R[%5.WM\5"* M7_;M&C%O_P`#7J=488G[56$?\,'_`.W2_0]4T#P<='N4U#4O%'BOQ3JB*X6[ MUS4XH;2(RQF.4V^A:):V&E0[E)`8V;NH/#YY/G5L3SQ<*>'I8:G_`"TXN_=7 MJ3G0-XBBN-`\7Z7`UOH MGC?18H1JUG`69Q8:A!*!%K6D^8S/]EG*E&9F@EA9W+>IDG$..R.;5!JMAIN\ MZ$V^1O\`FBUK3G_>CO\`:4K*V.(PM.NES>[);26Z]>Z\C\C?'?\`P3=_:)\+ M7,Y\+0^&?B+I2%C!IF+)V_:-(\0/;I'-MQN6"\N1GH37Z3@^.,DK MQ2KNK@*G53@YP3ZVG3N[>L8GE3R[$0?N*,UTL^5_<[?F>0+^Q?\`M2&40CX, M^)5;>4W->^'DA!R1N,IUG:$_VLXKTO\`6CA]*_\`:E*RZMKI6A226YGVY MP)[^`#OZ'RL9QUDV&BUA55QM1;*,'2A?SG.TK?X8,VIY=7;7-:DO-W?W+_-' M[`?L_P#[-GPY_9T\/S:5X-M9KW6]42'_`(2/Q?JPBDUW7)(`2D3O$BI8:9'( MSM%8VX6-"VYS)(3(WYIG.>XW.JRJ8F2A2IW]E1A=4Z:?6V\I/K.6KZ66AZV' MPU/#1M!:O>3W?^2\D?"7[6O[$OQG^-?QOU_XA>#+CP7%H&I:1X&)(O M%-CX;M]+_P"$>U2ZU%UDTJ?5Y;K[4+C3K7REVWT.PJ7R=V<8Y\SBS/\``9S3 MP,<$JL7AI57+VD%#2:@E:TI7^%WV-<%A:F&=1SM[R5K/M?R7<_0^OBCT#\?/ MVHOV&?C9\7OCGXW^(GA&X\$1^'_$!T`V":OKM]9Z@/[-\-:1I-S]HMH='G2/ M-U93E<2ME"I."<#],X?XMRK*\HPF!Q$:_MJ'M.;DIQ=2'*HRM:[L]$D^AW'P%_8Z^+OPU^#'[1_@+Q%/X0;7?BIX:LM)\+MI MNLWES8)=6^G:[:R'5+B32XFM(O-U*WPR1S$C><<8/)F_$V6XW-,CQE"-:-'+ MJLIU5*$5*SE3?N)3:;M%[M="Z&#JTJ.(IRY;U$E&STZ[Z:;GR*__``3,_:1, M;*+OX;9*,H_XJ?4NI!`_YE^OI%QYD=_@Q/\`X*A_\L.3^S<1_<_\"?\`D?7G M[5/['?Q<^,=G\$H/!\_A"-_A]\-;7PGKW]L:S>62MJL$6EH[:>8=+G^T6F;2 M;$CB(GY?EYX^:X>XFRW*I9J\3&M;&8IUJ?)"+M!N?Q7G&S]Y:*_J=>*P=6JJ M/)RKV<.5W=M=-M#)_8^_8N^,7P,^,UKX\\;7'@U]"@\-:_I+)H>M7E]?"ZU- M;06Q%O/I-NOE9A?:^JF]=> MVHL)@ZV'K*NOE9'ZOU^='J'(>//`?A/XE^%-7\$^-='MM;\.:W;^ M1>V-P"I5E(>"[M)XR)+.^MY@LL-Q"R21N@92*Z<'C,1E^(I8K"570KT7>+7X MIK:49+247HUN1.G"I!PG&\7T_KJ?C)\6?^"8OQ(T/4+J\^#WB#2?&F@22N]I MHOB*\CT#Q18Q$EEMFO7B_LW50BX43F2Q9L9:+))K]1RWCW`U(1AF5&>$K16L MZ474I-]^5/GA?M::7<\BKEM2#_4>;^T5;LJ5;F^[V9S_4<4G;V6WG M%+\SZW^!W_!,C7WU6QUSX\:WIEGHUI*D[^!O"MY+?7NJ-&P86FLZ^(HH;&Q; MI)'8">61=RK/%G=7S>;<>48TYTK%1C"_6%.[ EX-99.2 4 dp04069_ex9902.htm
     
    EXHIBIT 99.02
  Hampshire International Business Park
Chineham Basingstoke
Hampshire RG24 8EP
United Kingdom
Tel +44 (0)1256 894000
Fax +44 (0)1256 894708
www.shire.com
     
  Press Release  
     

21 November 2006

Shire plc (the "Company")

Notification of the Exercise of an Option and Sale of Shares by a Director.

The Company was notified by Mr Angus Russell, Chief Financial Officer on 20 November 2006 of the exercise in London on the same day, of an option over 45,819 ordinary 5p shares in the capital of the Company at an exercise price of £7.175.

The Company was further notified by Mr Russell on 20 November 2006 of the sale in London on the same day of the same 45,819 ordinary 5p shares in the capital of the Company at a price of £10.56.

Following these transactions, Mr Russell’s holding of ordinary 5p shares in the capital of the Company remains unchanged at 1,882.

The options exercised by Mr Russell were granted on 13 December 1999 and were due to expire on 12 December 2006.

T May
Company Secretary

For further information please contact:

Investor Relations Cléa Rosenfeld (Rest of the World) +44 1256 894 160
  Brian Piper (North America) +1 484 595 8252

Notes to editors

SHIRE PLC
Shire’s strategic goal is to become the leading specialty pharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire

Registered in England 2883758 Registered Office as above






believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

Shire’s focused strategy is to develop and market products for specialty physicians. Shire’s in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.

For further information on Shire, please visit the Company’s website: www.shire.com.

 

 

Registered in England 2883758 Registered Office as above






-----END PRIVACY-ENHANCED MESSAGE-----